A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
for
Hypercholesterolaemia
Location: Sherbrooke, Millville NJ, Stouffville,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07619131
Phase3, Recruiting
Active & ResponsiveNew
A Study to Evaluate Efficacy, Safety, and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
for
Chronic Pruritus of Unknown Origin
Location: Brighton MA, Tampa FL, Mayfield Heights OH,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07811869
Phase3, Recruiting
New
Paired Stimulation Plasticity for Motor Recovery in Humans With and Without Spinal Cord Injury
for
Healthy Control, Spinal Cord Injury
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab
Sex: All
Age: 19 - 70+
Code: NCT07814313
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Behavioral Activation for Treatment of Depression in Autistic Adolescents With Below Average Intelligence
for
Autism, Depressed, Depressed Mood
Location: Stony Brook NY
Sponsor: Stony Brook University
Sex: All
Age: 12 - 17
Code: NCT07812870
Recruiting
Active & ResponsiveNew
Targeted Ablation to Isolate Scar Channels Causing Ventricular Tachycardia
CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
for
HSIL, High Grade Squamous Intraepithelial Lesion,
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 21+
Code: NCT06949800
Phase2, Recruiting
New
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
for
Multiple Sclerosis
Location: Atlanta GA, Cordova TN
Sponsor: Genentech, Inc.
Sex: All
Age: 18 - 65
Code: NCT07609719
Recruiting
Active & ResponsiveNew
Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib
for
HER2+ Metastatic Breast Cancer (MBC)
Location: Durham NC
Sponsor: Duke University
Sex: Female
Age: 18+
Code: NCT06983691
Recruiting
New
Daily Knee Sleeve Use Versus No Use in Older Adults With Chronic Knee Pain
for
Knee Arthritis, Osteoarthritis
Location: Springfield MA
Sponsor: Margaret L Gourlay, MD, MPH
Sex: All
Age: 50 - 64
Code: NCT07674901
Recruiting
Active & ResponsiveNew
A Study of MX006 in Patients With Advanced and/or Metastatic Tumors Known to Express B7-H3
for
Advanced and/or Metastatic Solid Tumors Known to Express B7-H3
Location: Fairfax VA, Sarasota FL, Houston TX, San Antonio TX
Sponsor: Myricx Pharma Limited
Sex: All
Age: 18+
Code: NCT07807241
Phase1, Recruiting
New
Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New York NY, Houston TX
Sponsor: OncoC4, Inc.
Sex: All
Age: 18+
Code: NCT07408258
Phase1, Recruiting
New
Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)
for
Metastatic Prostate Cancer
Location: Little Rock AR
Sponsor: University of Arkansas
Sex: Male
Age: 18+
Code: NCT07224009
Phase2, Recruiting
New
A Prompt REstart Study of Renin-Angiotensin System Inhibitors After Acute Kidney Injury
for
Acute Kidney Injury
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT07734636
Recruiting
New
Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
for
Hematologic, Oncologic, Bone Marrow
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT07743476
Recruiting
New
Evaluation of 4D Intracardiac Echocardiography (ICE) During Structural Heart and Electrophysiology Procedures
for
Atrial Fibrillation
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT07806890
Recruiting
New
Snacks and Brain Health
for
Cognitive Assessment, Psychological Function, GI Health
Location: Lubbock TX
Sponsor: Texas Tech University Health Sciences Center
Sex: All
Age: 50+
Code: NCT07348406
Phase1, Phase2, Recruiting
New
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence